Anaemia-related impairment in quality of life in elderly cancer patients prior to chemotherapy

Journal of Cancer Research and Clinical Oncology

Volumn 133, Issue 5, 2007, Pages 279-286

  Wedding, Ulrich ^a,b   Röhrig, Bernd ^a,c   Pientka, Ludger ^b   Höffken, Klaus ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Anaemia; Cancer; Functional status; Karnofsky Performance Status; Quality of life

Indexed keywords

ADULT; AGE; AGED; ANALYSIS OF VARIANCE; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CONTROLLED STUDY; FEMALE; FUNCTIONAL DISEASE; HEMOGLOBIN BLOOD LEVEL; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; UNIVARIATE ANALYSIS;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANEMIA; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 34248192889     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-006-0167-8     Document Type: Article

References (27)

1. Aaronson NK, Ahmedzai S, et al (1993) The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365-376
2. Bokemeyer C, Aapro MS, et al (2004) EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer. Eur J Cancer 40(15):2201-2216
3. Boogaerts M, Coiffier B, et al (2003) Impact of epoetin beta on quality of life in patients with malignant disease. Br J Cancer 88(7):988-995
4. Bottomley A, Vanvoorden V, et al (2003) The challenges and achievements involved in implementing quality of life research in cancer clinical trials. Eur J Cancer 39(3):275-285
5. Buccheri G, Ferrigno D, et al (1996) Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 32A(7):1135-1141
6. Chaves PH, Ashar B, et al (2002) Looking at the relationship between hemoglobin concentration and prevalent mobility dificulty in older women. Should the criteria currently used to define anemia in older people be reevaluated? J Am Geriatr Soc 50(7):1257-1264
7. Chaves PH, Xue QL, et al (2004) What constitutes normal hemoglobin concentration in community-dwelling disabled older women? J Am Geriatr Soc 52(11):1811-1816
8. Conill C, Verger E, et al (1990) Performance status assessment in cancer patients. Cancer 65(8):1864-1866
9. Edwards BK, Howe HL, et al (2002) Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer 94(10):2766-2792
10. Guralnik JM, Eisenstaedt RS, et al (2004) Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 104(8):2263-2268
11. Hjermstad MJ, Fayers PM, et al (1998) Health-related quality of life in the general Norwegian population assessed by the European organization for research and treatment of cancer core quality-of-life questionnaire: the QLQ = C30 (+3). J Clin Oncol 16(3):1188-1196
12. Jordhoy MS, Fayers P, et al (2001) Quality of life in advanced cancer patients: the impact of sociodemographic and medical characteristics. Br J Cancer 85(10):1478-1485
13. Karnofsky DA, Adelmann WH, et al (1948) The use of nitrogen mustard in the palliative treatment of carcinoma. Cancer 1:634-656
14. Kempen GI, Ormel J, et al (1997) Adaptive responses among Dutch elderly: the impact of eight chronic medical conditions on health-related quality of life. Am J Public Health 87(1):38-44
15. King MT (1996) The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 5(6):555-567
16. Lind M, Vernon C, et al (2002) The level of haemoglobin in anaemic cancer patients correlates positively with quality of life. Br J Cancer 86(8):1243-1249
17. Ludwig H, Van Belle S, et al (2004) The European cancer anaemia survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer 40(15):2293-2306
18. Michelson H, Bolund C, et al (2000) Multiple chronic health problems are negatively associated with health related quality of life (HRQoL) irrespective of age. Qual Life Res 9(10):1093-1104
19. Mor V, Laliberte L, et al (1984) The Karnofsky performance status scale. An examination of its reliability and validity in a research setting. Cancer 53(9):2002-2007
20. Parkin DM, Bray F, et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74-108
21. Pinquart M, Duberstein PR (2004) Information needs and decision-making processes in older cancer patients. Crit Rev Oncol Hematol 51(1):69-80
22. Sawhney R, Sehl M, et al (2005) Physiologic aspects of aging: impact on cancer management and decision making, part I. Cancer J 11(6):449-460
23. Schaafsma J, Osoba D (1994) The Karnofsky performance status scale re-examined: a cross-validation with the EORTC-C30. Qual Life Res 3(6):413-424
24. Schwarz R, Hinz A (2001) Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 37(11):1345-1351
25. Van Belle SJ, Cocquyt V (2003) Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy. Crit Rev Oncol Hematol 47(1):1-11
26. Yates JW, Chalmer B, et al (1980) Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 45(8):2220-2224
27. Yellen SB, Cella DF, et al (1997) Measuring fatigue and other anemia-related symptoms with the functional assessment of cancer therapy (FACT) measurement system. J Pain Symptom Manage 13(2):63-74